BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Sea Run Holdings, Inc.

Sea Run Holdings, Inc. is maximizing an opportunity by merging a low margin business (salmon raising) into a high margin business in the biomedical field. The value of the blood per fish could significantly enhance the value of the same fish used for food. Sea Run has shown that salmon blood products can successfully compete against mammalian blood products. Companies in the bovine/human blood field have an interest in not changing from a mammalian product to a fish product, yet a fish blood source can have as many applications and be much safer than either bovine or human blood sources. In fact, some of Sea Run's products offer distinct advantagesScientists at Sea Run Holdings believe that a transmissible spongiform encephalopathy (TSE), like mad-cow disease, may occur in humans in the U.S. It is, in their opinion, a serious danger, since a TSE, chronic wasting disease, has already been documented in deer and elk in the U.S. and Canada. At this juncture, a gradual change to salmon, rather than bovine blood products could be prudent, if not necessary in the near future.Sea Run Holdings is offering a large supply of an alternative blood source that can continue to provide the same benefits as bovine or human blood for countless applications.


Contact Details:
76 Pine Street
Free port
Maine
United States of America
Tel:207-865-9655
Fax:
Email:info@searunholdings.com
WWW:

www.searunholdings.com/




BioNews Results for Sea Run Holdings, Inc.:

The Canadian Press Business News Budget for Monday, July 21, 2008
Calibre Macro World:  Jul 22 2008 8:53AM Matching: sea run holdings inc

Sea Run Holdings, Inc. Patents:

US Patent No.Title
6861255 Method of using fish plasma components for tissue culture
6599740 Method of using fish plasma components for tissue culture
6562621 Method of using fish ovarian fluid for culture and preservation of mammalian cells
6007811 Method of producing fibrin sealant from clotting factors in fish blood
5602041 Fish serum as a blocking reagent

View more Sea Run Holdings, Inc. patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 123 times since April 2007, the link to the organisation's website has been followed 23 times

Recent Search Terms used to find this page: sea run holdings | Sea Run Holdings | .

Search for more companies in Free port

Search for more companies in Maine



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Sea Run Holdings, Inc.
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.